IPSC - Century Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
3.38%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 0 | $0 | -- | -5,964,678 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-14 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | 31,172 | $1.92 | $60K |
| 2026-08-03 | Carr Douglas | officer: SVP Finance & Operations | SELL | 275 | $1.98 | $543 |
| 2026-06-12 | Russotti Gregory | officer: See Remarks | SELL | 2,584 | $2.23 | $6K |
| 2026-06-12 | Carr Douglas | officer: SVP Finance & Operations | SELL | 1,654 | $2.23 | $4K |
| 2026-06-11 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | 13,849 | $2.24 | $31K |
| 2026-06-11 | Cowan Chad | officer: Chief Scientific Officer | F-InKind | 358 | $2.24 | $801 |
| 2026-06-11 | Murphy Martin Patrick | director | A-Award | 74,000 | $2.24 | $166K |
| 2026-06-11 | Lee Han Myung | director | A-Award | 74,000 | $2.24 | $166K |
| 2026-06-11 | Riva Alessandro | director | A-Award | 74,000 | $2.24 | $166K |
| 2026-06-11 | Quimi Daphne | director | A-Award | 74,000 | $2.24 | $166K |
| 2026-06-11 | Blackwell Kimberly | director | A-Award | 74,000 | $2.24 | $166K |
| 2026-06-08 | Russotti Gregory | officer: See Remarks | SELL | 524 | $2.11 | $1K |
| 2026-06-08 | Carr Douglas | officer: SVP Finance & Operations | SELL | 249 | $2.11 | $525 |
| 2026-06-05 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | 463 | $2.13 | $986 |
| 2026-05-15 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | 31,172 | $2.34 | $73K |
| 2026-05-04 | Carr Douglas | officer: SVP Finance & Operations | SELL | 264 | $2.34 | $618 |
| 2025-12-09 | Murphy Martin Patrick | director | A-Award | 88,000 | $0.59 | $52K |
| 2025-12-09 | Murphy Martin Patrick | ? | -- | -- | -- | |
| 2026-04-01 | Cowan Chad | officer: Chief Scientific Officer | F-InKind | 1,365 | $2.19 | $3K |
| 2026-03-12 | Carr Douglas | officer: SVP Finance & Operations | SELL | 7,043 | $2.55 | $18K |
| 2026-03-12 | Russotti Gregory | officer: See Remarks | SELL | 10,076 | $2.55 | $26K |
| 2026-03-11 | Cowan Chad | officer: Chief Scientific Officer | F-InKind | 1,431 | $2.73 | $4K |
| 2026-03-11 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | 55,397 | $2.73 | $151K |
| 2026-03-09 | Carr Douglas | officer: SVP Finance & Operations | SELL | 247 | $2.54 | $626 |
| 2026-03-09 | Russotti Gregory | officer: See Remarks | SELL | 479 | $2.54 | $1K |